1. Home
  2. RGCO vs PLX Comparison

RGCO vs PLX Comparison

Compare RGCO & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RGC Resources Inc.

RGCO

RGC Resources Inc.

SELL

Current Price

$23.83

Market Cap

225.0M

Sector

Utilities

ML Signal

SELL

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

SELL

Current Price

$2.69

Market Cap

207.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RGCO
PLX
Founded
1912
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
225.0M
207.1M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
RGCO
PLX
Price
$23.83
$2.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $11.00
AVG Volume (30 Days)
8.2K
★ 715.5K
Earning Date
11-18-2026
11-10-2026
Dividend Yield
★ 3.86%
N/A
EPS Growth
★ 11.21
N/A
EPS
★ 1.37
0.27
Revenue
★ $95,334,212.00
$52,744,000.00
Revenue This Year
$15.70
$30.17
Revenue Next Year
$4.44
N/A
P/E Ratio
$16.70
★ $9.39
Revenue Growth
★ 12.63
N/A
52 Week Low
$20.55
$1.65
52 Week High
$27.17
$3.19

Technical Indicators

Market Signals
Indicator
RGCO
PLX
Relative Strength Index (RSI) 51.81 49.45
Support Level $20.89 $2.59
Resistance Level $23.03 $2.75
Average True Range (ATR) 0.72 0.09
MACD -0.02 -0.00
Stochastic Oscillator 54.78 51.72

Price Performance

Historical Comparison
RGCO
PLX

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: